Baseline ECG Before Starting Antipsychotics in Children
Children should receive a baseline ECG before initiating antipsychotic medication if they have cardiac risk factors (personal or family history of cardiac disease, arrhythmias, sudden cardiac death, or concurrent QT-prolonging medications), but routine ECG screening is not mandatory for all children without these risk factors. 1, 2
Risk-Stratified Approach to ECG Screening
Medical History Requirements (All Children)
Before prescribing antipsychotics, obtain a comprehensive medical history focusing on:
- Personal cardiac history: structural cardiac abnormalities, arrhythmias, syncope, near-syncope, palpitations, chest pain, or dyspnea 1, 2
- Family history: malignant arrhythmias, sudden cardiac death, or genetic predisposition to arrhythmias 1, 3
- Current medications: assess for QT-prolonging drugs, drug interactions, or potassium-wasting medications 2
- Medical conditions: electrolyte disturbances, ischemic heart disease, or structural heart disease 2
When Baseline ECG Is Indicated
Obtain a baseline ECG if any of the following are present:
- Positive cardiac history (personal or family) as outlined above 1, 2
- Concurrent use of other QT-prolonging medications 2
- Known electrolyte disturbances 2
- Structural heart disease or cardiac symptoms 2
- Female patients (who show greater QTc changes with antipsychotics) 4
When Baseline ECG May Be Omitted
In the absence of cardiac risk factors, routine screening ECGs have extremely low diagnostic yield (only 2.4% potentially relevant findings) and do not impact psychiatric admission or treatment decisions 5. The overall risk of torsades de pointes and sudden death with antipsychotics is low in healthy children 6.
Follow-Up ECG Monitoring
Timing of Repeat ECGs
If a baseline ECG is obtained and treatment proceeds:
- Repeat ECG at steady-state (1-2 weeks after initiation, approximately 5 drug half-lives) for medications with higher cardiac risk 2
- After significant dose increases 2
- After changes in psychotropic medication regimen (when QTc prolongation most commonly occurs) 4
Critical ECG Thresholds
- QTc > 500 ms or increase > 60 ms from baseline: discontinue the medication in most cases 2
- QTc 450-470 ms: borderline, requires close monitoring 4
- QTc ≥ 470 ms but < 500 ms: prolonged, consider medication adjustment or cardiology referral 2, 4
Medication-Specific Considerations
Recent evidence shows that low-to-moderate dose second-generation antipsychotics (risperidone, aripiprazole, quetiapine) cause statistically significant but clinically minimal QTc changes in children 4, 3. Risperidone shows slightly greater effects on QTc and QT dispersion compared to aripiprazole, though both remain within normal ranges in most patients 3.
Special Populations Requiring Enhanced Monitoring
- Female patients: demonstrate significantly greater QTc prolongation (31.7 ms vs 13.2 ms in males) 4
- Patients on concurrent ADHD medications: require careful monitoring, though combination therapy appears relatively safe 7
- Elderly patients: have dramatically increased baseline sudden cardiac death risk 2
Common Pitfalls to Avoid
- Do not obtain routine screening ECGs in all children without risk factors—this represents low-value care with minimal clinical impact 5
- Do not ignore medication changes: QTc prolongation most commonly appears after adjustments to the psychotropic regimen, not at initial prescription 4
- Do not rely solely on baseline ECG: follow-up monitoring at steady-state is essential for detecting drug-induced changes 2
- Do not dismiss family history: genetic predisposition to arrhythmias significantly increases risk even in otherwise healthy children 3